Date:  03/03/2009

Time:   11:30 am Networking and Registration 12:00-2:00 pm Lunch and Program

Location:   755 Page Mill Road Palo Alta, CA

Moderator:   Stephen B. Thau

Speaker:   Kristian E. Wiggert

Contact:   Cheryl Calderon

Contact Phone:  650-813-5746

Description:  

This program has been cancelled.

It is likely that the equity and debt markets will remain closed
throughout 2009 and into the foreseeable future to all but the largest
pharmaceutical, biotechnology, and medical device companies. How can the rest of the market access the capital needed to make the most of the growth opportunities?

Royalty monetization and revenue interest financing offer innovative companies attractive and available alternatives to their financing challenges. These financing vehicles can be tailored to meet a company's individual, near-term financial needs without the dilution associated with equity financing, the restrictive covenants of commercial debt, or the sacrifice of long-term value associated with product development partnerships.

Join your colleagues, Paul Capital Healthcare, and Morrison & Foerster LLP for an interactive discussion of how to put royalty monetization and revenue interest financing to work in achieving your corporate growth objectives.

Moderator:
Stephen B. Thau

Speakers:
Warren D. Cooper, President and Chief Executive Officer, Prism Pharmaceuticals, Inc.
John Leone, Partner, Paul Capital Healthcare
Kristian Wiggert, Morrison & Foerster LLP

This seminar will also be presented in San Diego.